ConductScience.org, home

Paper41511367

MicroRNAs in Prostate Cancer Liquid Biopsies: Early Detection, Prognosis, and Treatment Monitoring.

Yaghoubi SM and 7 others. Cells, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. MicroRNAs in Prostate Cancer Liquid Biopsies: Early Detection, Prognosis, and Treatment Monitoring. Papers, record 41511367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41511367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MicroRNAs in Prostate Cancer Liquid Biopsies: Early Detection, Prognosis, and Treatment Monitoring.
PubMed
Journal
Cells
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-06-25
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yaghoubi SMSeyyed Mohammadhttps://orcid.org/0009-0006-3423-5336
2Zare EErfanhttps://orcid.org/0000-0001-7899-8593
3Jafari Dargahlou SSina
4Jafari MMaryam
5Azimi MMahdiye
6Khoshnazar MMaedehhttps://orcid.org/0009-0002-3168-7709
7Shirjang SSolmaz
8Mansoori BBehzadhttps://orcid.org/0000-0001-9444-7134

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
MicroRNAsMajor topic
Early Detection of CancerMajor topic
Humans
Male
Liquid Biopsy
Prognosis
Biomarkers, Tumor
Circulating MicroRNA

Source PubMed

Download CSV of topics

References95

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120842666Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.Prostate2011https://conductscience.org/library/papers/20842666PubMed
228617988MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.Prostate2017https://conductscience.org/library/papers/28617988PubMed
331122242Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy.J Transl Med2019https://conductscience.org/library/papers/31122242PubMed
422674191Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.Prostate2013https://conductscience.org/library/papers/22674191PubMed
528910345Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.PLoS One2017https://conductscience.org/library/papers/28910345PubMed
627270433A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.Oncogene2017https://conductscience.org/library/papers/27270433PubMed
732091413Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.J Clin Invest2020https://conductscience.org/library/papers/32091413PubMed
840075682Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot Study.Cancers (Basel)2025https://conductscience.org/library/papers/40075682PubMed
921822286Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.Nat Med2011https://conductscience.org/library/papers/21822286PubMed
1039075471Investigating miR-6880-5p in extracellular vesicle from plasma as a prognostic biomarker in endocrine therapy-treated castration-resistant prostate cancer.BMC Cancer2024https://conductscience.org/library/papers/39075471PubMed
1133317606Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.J Exp Clin Cancer Res2020https://conductscience.org/library/papers/33317606PubMed
1241038275Total quantification of circulating microRNAs and smallRNAs in plasma and urine as prognostic biomarkers in prostate cancer.Actas Urol Esp (Engl Ed)2025https://conductscience.org/library/papers/41038275PubMed
1334534639miRNAs and androgen deprivation therapy for prostate cancer.Biochim Biophys Acta Rev Cancer2021https://conductscience.org/library/papers/34534639PubMed
1419676045Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.Int J Cancer2010https://conductscience.org/library/papers/19676045PubMed
1539854955CIRCULATING miR-1-3p, miR-96-5p, miR-148a-3p, and miR-375-3p Support Differentiation Between Prostate Cancer and Benign Prostate Lesions.Clin Genitourin Cancer2025https://conductscience.org/library/papers/39854955PubMed
1631068988Epidemiology of Prostate Cancer.World J Oncol2019https://conductscience.org/library/papers/31068988PubMed
1725053345miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.Prostate2014https://conductscience.org/library/papers/25053345PubMed
1830845775Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis.Int J Mol Sci2019https://conductscience.org/library/papers/30845775PubMed
1927990656Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.Prostate2017https://conductscience.org/library/papers/27990656PubMed
2026506397MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer.J Clin Med2015https://conductscience.org/library/papers/26506397PubMed

See all 95 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42837038Recent advances in discriminating prostate cancer from benign prostatic diseases in the pre-biopsy population.Med Oncol2026https://conductscience.org/library/papers/42837038PubMed
42792929Circulating Tumor Function: A Systems Biology Framework for Liquid Biopsy in Genitourinary Cancers.Genes (Basel)2026https://conductscience.org/library/papers/42792929PubMed
42642447MicroRNA profiles of prostate cancer bone metastases and miR-375 as an inhibitor of the aggressive metastasis subtype MetB.Sci Rep2026https://conductscience.org/library/papers/42642447PubMed
42512339Liquid Biopsy Meets Assembloids: PSA/miRNA/IL in Prostate Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42512339PubMed
42261618The Role of Exosomes in Bone Metastasis and Bone Tissue Engineering: Molecular Mechanisms and Therapeutic Opportunities.Biotechnol J2026https://conductscience.org/library/papers/42261618PubMed
41681860Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation.Cancers (Basel)2026https://conductscience.org/library/papers/41681860PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
MIR141406933PubTator's text mininghttps://conductscience.org/library/genes/406933NCBI Gene
MIR20A406982PubTator's text mininghttps://conductscience.org/library/genes/406982NCBI Gene
MIR21406991PubTator's text mininghttps://conductscience.org/library/genes/406991NCBI Gene
MIR326442900PubTator's text mininghttps://conductscience.org/library/genes/442900NCBI Gene
MIR375494324PubTator's text mininghttps://conductscience.org/library/genes/494324NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41511367

GET https://conductscience.org/api/papers/v1/41511367/references?page=2